240
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 5473-5489 | Published online: 18 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Temesgen Sidamo, Prakruti S Rao, Eleni Aklillu, Workineh Shibeshi, Yumi Park, Yong-soon Cho, Jae-Gook Shin, Scott K Heysell, Stellah G Mpagama & Ephrem Engidawork. (2022) Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis. Infection and Drug Resistance 15, pages 6839-6852.
Read now

Articles from other publishers (3)

Jingting Lu, Yuanyuan Xu, Zhipeng Li, Xiaoxiao Chen, Haijiang Lin & Qi Zhao. (2023) Diagnosis and Treatment Pathway of MDR/RR-TB in Taizhou, Zhejiang Province, China. Tropical Medicine and Infectious Disease 8:2, pages 79.
Crossref
Joseph Baruch Baluku, Olum Ronald, Peace Bagasha, Emmy Okello & Felix Bongomin. (2022) Prevalence of cardiovascular risk factors in active tuberculosis in Africa: a systematic review and meta-analysis. Scientific Reports 12:1.
Crossref
Igho J. Onakpoya. 2022. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 311 331 .